| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |